Source: Virtual Congress 2021 – COVID - 19 treatments



Rating:

Share or cite this content

Citations should be made in the following way:
A. Kharat (Genève, Switzerland), E. Dupuis-Lozeron (Genève, Switzerland), C. Cantero (Genève, Switzerland), C. Marti (Genève, Switzerland), O. Grosgurin (Genève, Switzerland), S. Lolachi (Genève, Switzerland), F. Lador (Genève, Switzerland), J. Plojoux (Genève, Switzerland), J. Janssens (Genève, Switzerland), P. Soccal (Genève, Switzerland), D. Adler (Genève, Switzerland). Self-proning in COVID-19 patients on low-flow oxygen therapy. A cluster randomised controlled trial. 3670

Member's Comments

No comment yet.

Related content which might interest you: Self-proning in COVID-19 patients on low-flow oxygen therapy: a cluster randomised controlled trial Source: ERJ Open Res, 7 (1) 00692-2020; 10.1183/23120541.00692-2020 Year: 2021 Humidified and standard oxygen therapy in acute severe asthma in children: a randomised controlled pilot trial (HUMOX) Source: International Congress 2018 – Paediatric asthma: prevention, diagnosis and treatment Year: 2018 Home rehabilitation in COPD patients on long term oxygen therapy (LTOT) : a multi-centre randomized controlled study Source: Eur Respir J 2002; 20: Suppl. 38, 233s Year: 2002 Comparison of continuous versus various demand oxygen delivery systems during standardized walking in COPD – a single-blinded, randomized, cross-over study Source: International Congress 2019 – Oxygen supplementation, noninvasive ventilation and mobility aspects of patients with impaired respiration Year: 2019 Resistance arm training in patients with COPD: A randomized controlled trial Source: Annual Congress 2010 - Exercise training and pulmonary rehabilitation Year: 2010 Randomized controlled crossover trial comparing CPAP with an autoCPAP device combined with pressure reduction during exhalation (autoC-FlexÔ) Source: Annual Congress 2009 - Continuous positive airway pressure therapy in obstructive sleep apnoea Year: 2009 Helium-hyperoxia a novel treatment for optimizing pulmonary rehabilitation: a randomized controlled trial Source: Eur Respir J 2007; 30: Suppl. 51, 327s Year: 2007 A randomised cross-over clinical testing of portable oxygen concentrators in patients with COPD Source: Annual Congress 2011 - Innovative methods in exercise testing Year: 2011 Diaphragmatic breathing training in COPD patients: A randomized, controlled and blinded trial Source: Annual Congress 2010 - Respiratory muscles and breathing: assessment and training Year: 2010 Acute effects of nasal high-flow during exercise in COPD patients after an exacerbation : a randomized controlled cross-over trial Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019 A phase III randomised controlled trial of single-dose triple therapy in COPD: the IMPACT protocol Source: Eur Respir J 2016; 48: 320-330 Year: 2016 Late Breaking Abstract - A randomised, double-blind, placebo controlled, clinical trial evaluating imatinib in patients with severe COVID-19 Source: Virtual Congress 2021 – Late breaking basic and translational science of SARS-Cov2 and COVID-19 Year: 2021 Evidence of efficacy for sequential combination therapy in recent randomized controlled trials (RCTs) Source: International Congress 2014 – Combination therapy in pulmonary arterial hypertension (PAH): the evidence grows Year: 2014 The combination of inspiratory muscle training and high-flow nasal cannula oxygen therapy for promoting weaning outcomes in difficult-to-wean patients: protocol for a randomised controlled trial Source: ERJ Open Res, 6 (3) 00088-2020; 10.1183/23120541.00088-2020 Year: 2020 Mindfulness-based cognitive therapy in COPD: a cluster randomised controlled trial Source: Eur Respir J, 51 (2) 1702082; 10.1183/13993003.02082-2017 Year: 2018 A double-blind randomised controlled trial of protein supplementation to enhance exercise capacity in COPD during pulmonary rehabilitation: a pilot study Source: ERJ Open Res, 7 (1) 00077-2021; 10.1183/23120541.00077-2021 Year: 2021 A phase-III multicenter, randomized, double-blind, controlled trial of high-dose inhaled nitric oxide in infants with acute bronchiolitis. Source: International Congress 2018 – Paediatric respiratory infections: mechanistic insights and clinical outcomes Year: 2018 Applicability of randomized controlled trials (RCTs) results to real-life patients in COPD Source: International Congress 2017 – Management of COPD Year: 2017 Effects of supplemental oxygen vs. room air in COPD patients: A randomized placebo-controlled trial Source: International Congress 2015 – Best abstracts in functional capacity in chronic lung diseases Year: 2015